COVID-19 Update: April 20, 2021
Blood cancer experts share how the COVID-19 pandemic is impacting their patients. Plus, meet the first two patients to receive the newly FDA approved CAR-T cell therapy for multiple myeloma.
Blood cancer experts share how the COVID-19 pandemic is impacting their patients. Plus, meet the first two patients to receive the newly FDA approved CAR-T cell therapy for multiple myeloma.
